This level of protection aligns with previous clinical trial data and underscores the vaccine’s potential to reduce hepatitis ...

Among these 87 patients with hepatitis E, nine had received a vaccine and 78 placebo, relating to a total vaccine efficiency of 88.5% (Figure 4). Among the subjects that completed three doses of ...

The U.S. capacity to battle hepatitis B and C has been leveled a devastating blow with the recent closure of the CDC’s ...

While most recover fully from hepatitis A, a vaccine-preventable and highly contagious infectious disease, outbreaks have ...

From a public health point of view, there are no specific strategies for prevention of hepatitis E virus infection. Exposures ...

Hepatitis A and hepatitis E are viral infections that primarily affect the liver and are transmitted through the fecal-oral ...

and Biological E’s pentavalent vaccine for diphtheria, tetanus, whooping cough (whole cell pertussis), hepatitis B, and Haemophilus influenzae type b. It is expected to enable fewer injections ...

Use the purifier to isolate the hepatitis B antigen produced by the yeast cells. The vaccine, once administered, will stimulate the immune system to attack the antigen (i.e., the protein coat).

They are considered protected if they have a hepatitis B surface antigen antibody (anti-HBs) titer of ≥10 mIU/mL after completing a full vaccination series. This study compared the effectiveness ...